Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis.

T M L TongM SamimE KapiteijnT S MeijerF M SpeetjensR BrüningT H SchroederS El-SanosyH MaschkeF K WackerA VogelC L A DewaldJ J GoemanM C Burgmans

Published in: Cardiovascular and interventional radiology (2022)

M-PHP is safe and effective in patients with UM liver metastases. Achieving CR, PR or SD is associated with improved survival. Primary tumor treatment with radiotherapy, normal baseline LDH and > 1 M-PHP cycles are associated with improved OS.

Keyphrases

liver metastases
patients undergoing
high dose
early stage
minimally invasive
radiation therapy
ultrasound guided
radiation induced
low dose
computed tomography
contrast enhanced
magnetic resonance imaging
radiofrequency ablation
replacement therapy
rectal cancer